---
title: "Syndax Pharmaceuticals, Inc — Ownership Dossier"
canonical: https://whiteintel.dev/entity/b82babcf-8177-555d-9e98-e5b4ff94d25e
json: https://whiteintel.dev/api/public/dossier/b82babcf-8177-555d-9e98-e5b4ff94d25e
identifier: oo:GB-COH-07608919
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Syndax Pharmaceuticals, Inc

**Type:** Company  
**Identifier:** `oo:GB-COH-07608919`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/b82babcf-8177-555d-9e98-e5b4ff94d25e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/b82babcf-8177-555d-9e98-e5b4ff94d25e  

## Ownership & control

### Owners / controllers

- **Syndax Pharmaceuticals, Inc** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/69cc6b5b-60cd-4c05-8719-6fe433dc90bf

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/07608919

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Syndax Pharmaceuticals, Inc**. Human view: https://whiteintel.dev/entity/b82babcf-8177-555d-9e98-e5b4ff94d25e · Structured JSON: https://whiteintel.dev/api/public/dossier/b82babcf-8177-555d-9e98-e5b4ff94d25e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._